seen from United States
seen from United States
seen from Tunisia
seen from Malaysia
seen from Germany
seen from China
seen from United States
seen from Indonesia
seen from Yemen
seen from United States
seen from Jordan
seen from Egypt
seen from United Kingdom
seen from China
seen from Germany
seen from Venezuela
seen from United States
seen from United States
seen from Jordan
seen from Australia
Neurocrine’s 33% quarter outruns weak drugmaker breadth, but average volume keeps the move under review
NBIX closed at $175.8, just 3.0% below its 52-week high, with an active weekly Trend Signal and positive Market Dynamics. The reservation is participation, with latest volume at only 1.0x the 13-week average.
Read the full Sharemaestro article.
Educational market research only. Not financial advice.
Neurocrine Biosciences Inc Tops Charts with Remarkable Financial Growth in 2023 https://csimarket.com/stocks/news.php?code=NBIX&date=2024-02-10120624&utm_source=dlvr.it&utm_medium=tumblr
Neurocrine Biosciences (NBIX) – Research Analysts’ Recent Ratings Updates
Neurocrine Biosciences (NBIX) – Research Analysts’ Recent Ratings Updates
Several analysts have recently updated their ratings and price targets for Neurocrine Biosciences (NASDAQ: NBIX): 12/8/2021 – Neurocrine Biosciences had its price target raised by analysts at Oppenheimer Holdings Inc. from $140.00 to $154.00. They now have an “outperform” rating on the stock. 12/8/2021 – Neurocrine Biosciences was upgraded by analysts at Zacks Investment Research from a “sell”…
View On WordPress
Neurocrine Biosciences Inc (NBIX) Q1 2019 Earnings Call Transcript Image source The Motley Fool Neurocrine Biosciences Inc NASDAQ NBIX Q1 160 2019 Earnings Call April 29 2019 4 30 p m ET Contents Prepared Remarks Questions and Answers Call Participants Prepared Remarks... Latest Articles in
Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Sets 52 Week High Bar Of $126.28
Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Sets 52 Week High Bar Of $126.28
Neurocrine Biosciences, Inc. (Nasdaq:NBIX)
September 4th, 2018
Amidst falling markets Neurocrine Biosciences, Inc. closed Monday up 2.36%, a $2.90 increase to close on $125.85. Furthermore it hit a new 52 week high of $126.28. The stock continues to trade well at 125% of its 52 week low of $55.88. (more…)
View On WordPress
Hitting 52 Week High, Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Finishes At $122.10
Hitting 52 Week High, Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Finishes At $122.10
Neurocrine Biosciences, Inc. (Nasdaq:NBIX)
August 30th, 2018
Amidst falling markets Neurocrine Biosciences, Inc. closed Thursday up 0.36%, a $0.44 increase to close on $122.10. Furthermore it hit a new 52 week high of $123.01. The stock continues to trade well at 134% of its 52 week low of $52.22. (more…)
View On WordPress
Setting 52 Week High, Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Close At $121.11
Setting 52 Week High, Neurocrine Biosciences, Inc. (Nasdaq:NBIX) Close At $121.11
Neurocrine Biosciences, Inc. (Nasdaq:NBIX)
August 27th, 2018
With markets going up Neurocrine Biosciences, Inc. went up $2.40 Monday, a 2.02% jump, closing at $121.11. Furthermore it hit a new 52 week high of $121.38. The stock continues to trade well at 136% of its 52 week low of $51.42. (more…)
View On WordPress
(Nasdaq:NBIX) Neurocrine Biosciences, Inc. Breaks 52 Week High Bar Of $120.90
(Nasdaq:NBIX) Neurocrine Biosciences, Inc. Breaks 52 Week High Bar Of $120.90
Neurocrine Biosciences, Inc. (Nasdaq:NBIX)
August 9th, 2018
Neurocrine Biosciences, Inc. closed the day up $2.50 Saturday, a 2.14% increase, closing at $119.36. Furthermore it hit a new 52 week high of $120.90. The stock continues to trade well at 135% of its 52 week low of $50.88. (more…)
View On WordPress
